Amayeza okuphulukana nobunzima uBelviq urhoxile kwimakethi yase-US phakathi kweenkxalabo eziphakamisa umngcipheko womhlaza

U-Belviq-isiyobisi sokuphulukana nobunzima-wasuswa kwimakethi yase-US ngenxa yesicelo sokurhoxa kwimakethi ye-FDA. Idatha ibonise ukwanda komngcipheko womhlaza xa kuthelekiswa ne-placebo.

I-FDA ivuma okokuqala i-Eliquis generic: apixaban

Abo basemngciphekweni wokubethwa sistroke kungekudala baya kuba nenye indlela yexabiso eliphantsi kune-Eliquis, egazini elincinanana. I-FDA ivume iinguqulelo ezi-2 ze-generic Eliquis (apixaban) ngoDisemba 2019.

I-FDA yamkela u-Erleada, unyango lomhlaza webala lobudoda

I-Erleada sisiyobisi sokuqala esivunyiweyo se-FDA sokunganyangeki kwehomoni, ukungasasazeki (ukumelana nokungahambisani nemastastatic) yamathumba-eza njengeendaba ezamkelekileyo kwizigulana ezinomhlaza wedlala lobudoda.

I-FDA ivuma i-Ervebo, iyeza lokuqala lokugonya i-Ebola

U-Ervebo, isitofu sokuqala se-Ebola sokuthintela intsholongwane siphawula isigxina sempilo yoluntu ukukhusela kwesi sifo sosulelayo.

Yonke into esiyaziyo malunga neFavilavir, unyango olunokubakho lwe-coronavirus

I-Favilavir sisiyobisi esingasebenziyo esisetyenziswa kunyango lwe-influenza eJapan kwaye ngoku siphantsi kovavanyo lweklinikhi ngokuchasene ne-COVID-19 e-China.

I-FDA ivuma i-Gilenya generic

Nge-5 ka-Disemba ka-2019 i-US Food and Drug Administration (i-FDA) yabhengeza ukwamkelwa kwe-fingolimod, uhlobo oluqhelekileyo lwe-Gilenya, ichiza elinyanga i-MS.

Iinguqulelo ezi-9 eziqhelekileyo zeLyrica ngoku ziyafumaneka ngexabiso eliphantsi kwizigulana

I-FDA ivume iinguqulelo ezili-9 ze-Lyrica generic (pregabalin) ukunciphisa iindleko zayo. I-anticonvulsant yohlobo oluqhelekileyo inokubiza i-320- $ 350 engaphantsi kwegama lika-Lyrica.

I-FDA ivuma amayeza okuqala omlomo okopha kakhulu kwi-uterine fibroids

Iyeza lomlomo liza kubakho kungekudala ukunciphisa ukopha okunzima ukuya exesheni (menorrhagia) ukusuka kwi-uterine fibroids, enkosi kwi-FDA-imvume ka-Oriahnn.

I-FDA ikhumbula iipilisi zokukhululwa ezandisiweyo ze-metformin

Ngomhla ka-Meyi ka-2020, i-FDA yakhupha isaziso sokukhumbula ngokuzithandela iipilisi ze-metformin ER 500 mg. NgoJan. 4, 2021, ukukhunjulwa kwandiswa.

Funda malunga ne-5 yamachiza amatsha eza ngo-2020

I-FDA ivuma amachiza amatsha rhoqo ngonyaka. Abanye beza ngqo kwintengiso, ngelixa abanye belibazisekile. Ezi zezona zinomdla kakhulu endleleni.

Amachiza enziwe afana nalawo aveliswe ngumenzi asandula ukufumaneka ngo-2019

Amayeza angamashumi amane sele efumanekile njengamayeza enziwe ngonyaka ka-2019. Jonga ukuba la machiza enziwe afana nalawo enziwe afana nalawo enziwe afana nalawo enziwe afana nalawo enziwe afana nalawo enziwe afana nalawo enziwe afana nalawo enziwe afana nalawo enziwe afana nalawo enziwe afana nalawo enziwe afana nalawo enziwe afana nalawo enziwe afana nalawo enziwe afana nalawo aveliswe ngabantu, makhe niwathelekise namanye.

I-FDA itsala zonke iintlobo ze-ranitidine kwintengiso yase-US

Ngaba ungumsebenzisi weZantac okanye igeneric yayo? Funda ukuba kuthetha ntoni oku kuwe njengoko iikhemesti ziyekile ukubonelela ngeepilisi ngenxa yokukhumbula i-ranitidine.

I-FDA yamkela iQelbree, iyeza elitsha le-ADHD elingavuseleliyo

I-Qelbree (viloxazine), iyeza lokuqala elinganyanzelisiyo le-ADHD kwiminyaka eli-10, liya kufumaneka kwizigulana kwikota yesibini ka-2021.

I-FDA ivuma utshintsho lwe-Rx-to-OTC yokuthambisa iintwala entloko

Le nto yokuthambisa yeentwala yentloko eyayifunyenwe ngaphambili, ngoku iyafumaneka kwi-counter.